Biosensics LLC
Newton, MA
- UEI
- C9MRZK4B7K39
- CAGE
- 4TN46
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 57 Chapel St #200, Newton, MA 02458, USA
- Website
- biosensics.com
- Founded
- 2007
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 38 Instruments & Related Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Digital assessment of motor skills in infants and young boys with duchenne muscular dystrophy using wearable sensors -… | National Insititue of Arthritis and Musculoskeletal and Skin Diseases | $314,362 | |
| Digital health technologies for monitoring motor function in progressive supranuclear palsy and dementia with lewy… | National Institute on Aging | $5,174,076 | |
| A wearable sensor platform for remote monitoring of motor impairment in huntingtons disease and prodromal huntingtons… | National Center for Advancing Translational Sciences | $3,094,232 | |
| FY24 sbir phase i topic no. 459 project title: an automated screening platform for early identification of… | National Cancer Institute | $400,000 | |
| Odalert: wearable device for automatic detection of opioid-induced respiratory arrest - in response to the escalating… | National Institute on Drug Abuse | $800,000 |
About Biosensics LLC
Biosensics LLC is a Newton, Massachusetts-based small business specializing in digital health technologies, with a primary focus on developing advanced wearable sensor platforms and innovative software solutions for medical research and monitoring. The company creates cutting-edge technologies that enable remote monitoring, early detection, and assessment of various neurological, cognitive, and motor-related conditions through sophisticated sensor and data analysis technologies. Biosensics is registered in SAM.gov and has been actively receiving federal contract and grant awards since 2007, demonstrating a consistent track record of technological innovation in healthcare diagnostics and monitoring.
Through federal contract awards, Biosensics has primarily focused on Small Business Innovation Research (SBIR) contracts with agencies like the National Institutes of Health (NIH) and the National Center for Advancing Translational Sciences. The company's contract work has centered on developing technological platforms for monitoring and screening various medical conditions, such as creating an automated screening platform for early identification of malnutrition in cancer patients and developing remote measurement technologies for clinical trials involving rare diseases. These contracts are consistently set aside for small businesses and typically involve definitive, firm-fixed-price agreements with ceiling values ranging from $325,000 to $2,000,000, demonstrating the company's capability to secure and execute innovative research and development projects for federal agencies.
Biosensics' federal grant awards reveal a robust portfolio of projects focused on developing advanced wearable sensor technologies for monitoring and detecting various neurological and medical conditions. The company has received substantial grants from agencies including the National Institute on Aging, National Institute on Drug Abuse, Defense Health Agency, and National Institute of Neurological Disorders and Stroke. These grants support the development of innovative technologies such as a wearable sensor platform for monitoring motor impairment in Huntington's disease, a multi-modal sensor for early detection of cognitive decline, an automated screening platform for hip bone fragility, and a wearable device for detecting opioid-induced respiratory arrest. Many of these grants involve collaborative partnerships with leading medical institutions like Massachusetts General Hospital, Harvard Medical School, and Baylor College of Medicine, highlighting Biosensics' reputation for developing cutting-edge digital health solutions that address critical medical research and monitoring challenges.
Contract vehicles
Quick answers
What is Biosensics LLC's UEI?
Biosensics LLC's Unique Entity ID (UEI) in SAM.gov is C9MRZK4B7K39.
What is Biosensics LLC's CAGE code?
Biosensics LLC's CAGE code is 4TN46.
What is Biosensics LLC's primary NAICS code?
Biosensics LLC's primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).
Where is Biosensics LLC located?
Biosensics LLC's physical address in SAM.gov is 57 Chapel St #200, Newton, MA 02458, USA.
Is Biosensics LLC registered in SAM.gov?
Yes. Biosensics LLC's SAM.gov registration is active through December 10, 2026.
Which contract vehicles does Biosensics LLC hold?
Biosensics LLC holds a place on 1 federal contract vehicle: FSS-65-II-A.
What is Biosensics LLC's most recent federal award?
Biosensics LLC's most recent federal grant award is Digital assessment of motor skills in infants and young boys with duchenne muscular dystrophy using wearable sensors -… (R41AR087264), from National Insititue of Arthritis and Musculoskeletal and Skin Diseases, on September 1, 2026.
On GovTribe
See Biosensics LLC's full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors